Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula (RAP)
Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-based Formula
Sponsor: Société des Produits Nestlé (SPN)
A observational or N/A phase clinical study on Enteral Feeding Intolerance, this trial is completed. The trial is conducted by Société des Produits Nestlé (SPN) and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Mar 2023 [monthly]
Completed
-
Aug 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Oct 2018 — Aug 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Société des Produits Nestlé (SPN)
For direct contact, visit the study record on ClinicalTrials.gov .